0000890821
EX-FILING FEES
0000890821
2025-12-22
2025-12-22
0000890821
1
2025-12-22
2025-12-22
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit
107
Calculation
of Filing Fee Tables
FORM
S-3
ENVERIC
BIOSCIENCES, INC.
Table
1: Newly Registered and Carry Forward Securities
| | |
Security Type | |
Security Class Title | |
Fee Calculation Rule | |
Amount Registered(1) | | |
Proposed Maximum Offering Price Per Unit |
| |
Maximum Aggregate Offering Price | | |
Fee Rate | | |
Amount of
Registration Fee | |
| Fees to Be Paid | |
Equity | |
Common Stock, par value $0.01 per share | |
Other | |
| 882,627 | | |
$ |
5.05 |
(2) | |
$ | 4,457,266.35 | | |
| 0.00013810 | | |
$ | 615.55 | |
| Total Offering Amounts |
| |
$ | 4,457,266.35 | | |
| | | |
$ | 615.55 | |
| Total Fees Previously Paid |
| |
| | | |
| | | |
| — | |
| Total Fees Offsets |
| |
| | | |
| | | |
| — | |
| Net Fee Due |
| |
| | | |
| | | |
$ | 615.55 | |
| (1) |
Pursuant
to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of Common Stock issuable
upon the conversion or exercise, as applicable, of the Warrants offered hereby also include an indeterminate number of additional
shares of Common Stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or
other similar transactions. |
| |
|
| (2) |
With
respect to the shares of Common Stock offered by the Selling Stockholders, estimated at $5.05 per share, the average of the high
($5.55) and low ($4.55) prices as reported on The Nasdaq Capital Market on December 15, 2025, for the purpose of calculating the
registration fee in accordance with Rule 457(c) under the Securities Act. |
N/A